These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 25860571)

  • 1. Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C.
    Masuda K; Chiyoda T; Sugiyama N; Segura-Cabrera A; Kabe Y; Ueki A; Banno K; Suematsu M; Aoki D; Ishihama Y; Saya H; Kuninaka S
    PLoS One; 2015; 10(4):e0125308. PubMed ID: 25860571
    [No Abstract]   [Full Text] [Related]  

  • 2. LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C.
    Masuda K; Chiyoda T; Sugiyama N; Segura-Cabrera A; Kabe Y; Ueki A; Banno K; Suematsu M; Aoki D; Ishihama Y; Saya H; Kuninaka S
    PLoS One; 2015; 10(2):e0118662. PubMed ID: 25723520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
    Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of LATS family proteins in ovarian tumors and its significance.
    Xu B; Sun D; Wang Z; Weng H; Wu D; Zhang X; Zhou Y; Hu W
    Hum Pathol; 2015 Jun; 46(6):858-67. PubMed ID: 25841306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative expression of zebrafish lats1 and lats2 and their implication in gastrulation movements.
    Chen CH; Sun YH; Pei DS; Zhu ZY
    Dev Dyn; 2009 Nov; 238(11):2850-9. PubMed ID: 19842174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.
    McPherson JP; Tamblyn L; Elia A; Migon E; Shehabeldin A; Matysiak-Zablocki E; Lemmers B; Salmena L; Hakem A; Fish J; Kassam F; Squire J; Bruneau BG; Hande MP; Hakem R
    EMBO J; 2004 Sep; 23(18):3677-88. PubMed ID: 15343267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor.
    Powzaniuk M; McElwee-Witmer S; Vogel RL; Hayami T; Rutledge SJ; Chen F; Harada S; Schmidt A; Rodan GA; Freedman LP; Bai C
    Mol Endocrinol; 2004 Aug; 18(8):2011-23. PubMed ID: 15131260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lats2, a putative tumor suppressor, inhibits G1/S transition.
    Li Y; Pei J; Xia H; Ke H; Wang H; Tao W
    Oncogene; 2003 Jul; 22(28):4398-405. PubMed ID: 12853976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
    Visser S; Yang X
    Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
    Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
    Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.
    Zhang J; Smolen GA; Haber DA
    Cancer Res; 2008 Apr; 68(8):2789-94. PubMed ID: 18413746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
    Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
    Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LATS2 is a tumor suppressor gene of malignant mesothelioma.
    Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
    Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane.
    Hergovich A; Schmitz D; Hemmings BA
    Biochem Biophys Res Commun; 2006 Jun; 345(1):50-8. PubMed ID: 16674920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction.
    St John MA; Tao W; Fei X; Fukumoto R; Carcangiu ML; Brownstein DG; Parlow AF; McGrath J; Xu T
    Nat Genet; 1999 Feb; 21(2):182-6. PubMed ID: 9988269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling.
    Clattenburg L; Wigerius M; Qi J; Rainey JK; Rourke JL; Muruganandan S; Sinal CJ; Fawcett JP
    Mol Cell Biol; 2015 Jul; 35(13):2265-77. PubMed ID: 25918243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Structure of an NDR/LATS Kinase-Mob Complex Reveals a Novel Kinase-Coactivator System and Substrate Docking Mechanism.
    Gógl G; Schneider KD; Yeh BJ; Alam N; Nguyen Ba AN; Moses AM; Hetényi C; Reményi A; Weiss EL
    PLoS Biol; 2015 May; 13(5):e1002146. PubMed ID: 25966461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity.
    Enomoto M; Kizawa D; Ohsawa S; Igaki T
    Dev Biol; 2015 Jul; 403(2):162-71. PubMed ID: 25967126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.